Q3 2023 · 13F-HR
Redmile Group, LLCholdings as filed
Filed 2023-11-14 · accession 0001104659-23-118113
$2.10B
Reported value
68
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $277.8M | 13.2% | 17,503,417 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $232.4M | 11.1% | 2,003,367 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $206.0M | 9.80% | 16,944,621 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $89.5M | 4.26% | 1,769,684 | Common | SOLE |
| 05105P107 | AUGX | AUGMEDIX INC | $80.5M | 3.83% | 15,630,327 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $71.2M | 3.39% | 4,163,922 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $58.2M | 2.77% | 1,100,492 | Common | SOLE |
| 24344T101 | DCPHEUR | DECIPHERA PHARMACEUTICALS IN | $56.9M | 2.71% | 4,475,384 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $46.4M | 2.21% | 2,678,099 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $45.0M | 2.14% | 1,635,938 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $42.4M | 2.02% | 2,574,042 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $42.3M | 2.01% | 1,102,514 | Common | SOLE |
| 75525N107 | — | RAYZEBIO INC | $41.2M | 1.96% | 1,857,706 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $40.9M | 1.94% | 774,200 | Common | SOLE |
| 148806102 | CTLTEUR | CATALENT INC | $39.8M | 1.89% | 873,966 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $37.5M | 1.78% | 155,076 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $37.2M | 1.77% | 85,378 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $35.9M | 1.71% | 5,661,230 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $35.3M | 1.68% | 1,469,725 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $33.6M | 1.60% | 4,733,248 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $32.3M | 1.54% | 929,900 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $29.1M | 1.39% | 59,851 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $29.0M | 1.38% | 2,404,695 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $27.8M | 1.32% | 13,124,427 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $27.0M | 1.28% | 1,774,252 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $26.0M | 1.24% | 1,868,507 | Common | SOLE |
| 863667101 | SYK | STRYKER CORPORATION | $25.9M | 1.23% | 94,738 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $24.8M | 1.18% | 2,971,542 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $22.8M | 1.08% | 244,391 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $22.4M | 1.07% | 2,848,827 | Common | SOLE |
| 29384C108 | TRDA | ENTRADA THERAPEUTICS INC | $20.3M | 0.97% | 1,284,000 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $20.0M | 0.95% | 2,053,333 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $15.3M | 0.73% | 3,872,696 | Common | SOLE |
| 39868T105 | 2JQ | GRITSTONE BIO INC | $14.6M | 0.70% | 8,509,126 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $14.3M | 0.68% | 419,568 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $13.5M | 0.64% | 518,924 | Common | SOLE |
| 159864107 | CRL | CHARLES RIV LABS INTL INC | $13.0M | 0.62% | 66,382 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $12.7M | 0.61% | 14,178,045 | Common | SOLE |
| 30050B101 | EVH | EVOLENT HEALTH INC | $12.7M | 0.60% | 465,282 | Common | SOLE |
| 74168J101 | PRME | PRIME MEDICINE INC | $12.6M | 0.60% | 1,324,350 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $11.8M | 0.56% | 761,955 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $10.7M | 0.51% | 809,777 | Common | SOLE |
| 00091E109 | ABSI | ABSCI CORPORATION | $10.6M | 0.50% | 8,031,094 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $9.4M | 0.45% | 4,135,061 | Common | SOLE |
| 046513107 | ATRAGBX | ATARA BIOTHERAPEUTICS INC | $9.3M | 0.44% | 6,280,813 | Common | SOLE |
| 85916J409 | STXS | STEREOTAXIS INC | $9.1M | 0.43% | 5,765,792 | Common | SOLE |
| 82024L103 | STTK | SHATTUCK LABS INC | $8.5M | 0.41% | 5,619,914 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $8.3M | 0.39% | 3,503,190 | Common | SOLE |
| 808644108 | — | SCIENCE 37 HOLDINGS INC | $7.9M | 0.38% | 19,808,234 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $7.1M | 0.34% | 427,490 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $6.2M | 0.29% | 1,283,289 | Common | SOLE |
| 40412C101 | HCA | HCA HEALTHCARE INC | $6.1M | 0.29% | 24,667 | Common | SOLE |
| 58406B202 | MDVLQ | MEDAVAIL HOLDINGS INC | $4.2M | 0.20% | 692,082 | Common | SOLE |
| 019818103 | — | ALLOVIR INC | $4.1M | 0.20% | 1,907,969 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $4.1M | 0.19% | 3,031,009 | Common | SOLE |
| N51517105 | 4PKB | LAVA THERAPEUTICS NV | $3.1M | 0.15% | 2,074,372 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $2.4M | 0.12% | 1,440,725 | Common | SOLE |
| 64049K203 | — | NEOLEUKIN THERAPEUTICS INC | $2.3M | 0.11% | 582,443 | Common | SOLE |
| 232109108 | CUTREUR | CUTERA INC | $2.0M | 0.10% | 334,996 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $1.9M | 0.09% | 1,046,587 | Common | SOLE |
| 00449L102 | 698 | ACHILLES THERAPEUTICS PLC | $1.5M | 0.07% | 1,608,089 | Common | SOLE |
| 46185L103 | NVTA1EUR | INVITAE CORP | $1.4M | 0.07% | 2,280,403 | Common | SOLE |
| 83444K105 | SLGCUSD | SOMALOGIC INC | $954,659 | 0.05% | 399,439 | Common | SOLE |
| 02080L102 | TKNO | ALPHA TEKNOVA INC | $793,934 | 0.04% | 284,564 | Common | SOLE |
| 43906K100 | HOOKGBP | HOOKIPA PHARMA INC | $655,282 | 0.03% | 1,063,769 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $558,173 | 0.03% | 715,607 | Common | SOLE |
| 835431107 | — | SONENDO INC | $306,071 | 0.01% | 410,393 | Common | SOLE |
| 04965G109 | BCELUSD | ATRECA INC | $115,532 | 0.01% | 442,653 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.